The Adult Vaccines Market report points out national and global business prospects and competitive conditions for Adult vaccines. Market size estimation and forecasts were given based on a detailed research methodology tailored to the conditions of the demand for Adult vaccines. The Adult vaccines market has been segmented by vaccine (influenza, tetanus/diphtheria/pertussis, varicella, human papillomavirus, zoster, measles/mumps/rubella, pneumococcal, hepatitis, and others), by vaccine type (monovalent and multivalent), by technology (live attenuated vaccines, inactivated viral or bacterial vaccines, toxoid vaccines, recombinant vaccines, and conjugate vaccines). Historical background for the demand of Adult vaccines has been studied according to organic and inorganic innovations in order to provide accurate estimates of the market size. Primary factors influencing the growth of the demand Adult vaccines have also been established with potential gravity. Major regions covered in the study include North America, Europe, Asia Pacific, Middle East & Africa, and South America.
- Human Papillomavirus
- and Others
By Vaccine Type:
- and Multivalent
- Live Attenuated Vaccines
- Inactivated Viral or Bacterial Vaccines
- Toxoid Vaccines
- Recombinant Vaccines
- and Conjugate Vaccines
North America Adult Vaccines Market
- North America, by Country
- North America, by Vaccine
- North America, by Vaccine Type
- North America, by Technology
Europe Adult Vaccines Market
- Europe, by Country
- The Netherlands
- Rest of Europe
- Europe, by Vaccine
- Europe, by Vaccine Type
- Europe, by Technology
Asia Pacific Adult Vaccines Market
- Asia Pacific, by Country
- South Korea
- Rest of Asia Pacific
- Asia Pacific, by Vaccine
- Asia Pacific, by Vaccine Type
- Asia Pacific, by Technology
Middle East & Africa Adult Vaccines Market
- Middle East & Africa, by Country
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
- Middle East & Africa, by Vaccine
- Middle East & Africa, by Vaccine Type
- Middle East & Africa, by Technology
South America Adult Vaccines Market
- South America, by Country
- Rest of South America
- South America, by Vaccine
- South America, by Vaccine Type
- South America, by Technology
Major Companies: GlaxoSmithKline Plc, Merck & Co., Sanofi Pasteur, Pfizer, Inc., CSL Limited, Johnson & Johnson, Serum Institute of India, Medimmune, and AstraZeneca Plc.
Years Covered in the Study:
Historic Year: 2017-2018
Base Year: 2019
Estimated Year: 2020
Forecast Year: 2028
Objectives of this report:
- To estimate market size for Adult vaccines market on regional and global basis.
- To identify major segments in Adult vaccines market and evaluate their market shares and demand.
- To provide a competitive scenario for the Adult vaccines market with major developments observed by key companies in the historic years.
- To evaluate key factors governing the dynamics of Adult vaccines market with their potential gravity during the forecast period.
Reasons to Buy This Report:
- Provides niche insights for decision about every possible segment helping in strategic decision making process.
- Market size estimation of the Adult vaccines market on a regional and global basis.
- A unique research design for market size estimation and forecast.
- Identification of major companies operating in the market with related developments
- Exhaustive scope to cover all the possible segments helping every stakeholder in the Adult vaccines market.
This study is customized to meet your specific requirements:
- By Segment
- By Sub-segment
- By Region/Country
- Product Specific Competitive Analysis
For more information, contact: [email protected]